Enzyme Mimics for the Catalytic Generation of Nitric Oxide from Endogenous Prodrugs

Tao Yang, Alexander N. Zelikin, Rona Chandrawati*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

40 Citationer (Scopus)

Abstract

The highly diverse biological roles of nitric oxide (NO) in both physiological and pathophysiological processes have prompted great interest in the use of NO as a therapeutic agent in various biomedical applications. NO can exert either protective or deleterious effects depending on its concentration and the location where it is delivered or generated. This double-edged attribute, together with the short half-life of NO in biological systems, poses a major challenge to the realization of the full therapeutic potential of this molecule. Controlled release strategies show an admirable degree of precision with regard to the spatiotemporal dosing of NO but are disadvantaged by the finite NO deliverable payload. In turn, enzyme-prodrug therapy techniques afford enhanced deliverable payload but are troubled by the inherent low stability of natural enzymes, as well as the requirement to control pharmacokinetics for the exogenous prodrugs. The past decade has seen the advent of a new paradigm in controlled delivery of NO, namely localized bioconversion of the endogenous prodrugs of NO, specifically by enzyme mimics. These early developments are presented, successes of this strategy are highlighted, and possible future work on this avenue of research is critically discussed.

OriginalsprogEngelsk
Artikelnummer1907635
TidsskriftSmall
Vol/bind16
Nummer27
Antal sider15
ISSN1613-6810
DOI
StatusUdgivet - jul. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Enzyme Mimics for the Catalytic Generation of Nitric Oxide from Endogenous Prodrugs'. Sammen danner de et unikt fingeraftryk.

Citationsformater